Esperion releases positive PhII results; Safety warnings at India, China manufacturing sites spell trouble for global supply chain
→ After lining up a new $200 million funding deal for the projected commercial launch of bempedoic acid next year, Esperion announced today …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
